AzTrials
AzTrials

Fluid Responsiveness Predictability in SepsisNCT07653568

A Study Comparing Carotid Doppler Ultrasound and Echocardiography to Assess Fluid Responsiveness in Septic Patients on Ventilator

A study testing intravenous crystalloid fluid bolus in people with Fluid Responsiveness Predictability in Sepsis, run by Pakistan Institute of Medical Sciences at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to determine whether common carotid artery blood flow measured by bedside Doppler ultrasound can accurately identify fluid responsiveness in mechanically ventilated adults with sepsis. Read more about this study

Who is it for?
Ages 12 years and older
What is being tested?
intravenous crystalloid fluid bolus
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
94 participants
Where
1 sitePakistan
Study dates
1 May 2026to 29 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • • Adults with sepsis requiring mechanical ventilation in the intensive care unit
  • Patients requiring fluid assessment or fluid resuscitation based on clinical findings, including one or more of the following:
  • Heart rate greater than 100 beats per minute
  • Systolic blood pressure less than 90 mmHg
  • Mean arterial pressure less than 65 mmHg
  • Urine output less than 0.5 mL/kg/hour for at least 2 hours

Who cannot join

  • Intracranial pathology associated with raised intracranial pressure, including intracerebral hemorrhage or space-occupying lesions
  • Recent neurosurgical procedures or conditions where passive leg raising may increase intracranial pressure
  • Known heart failure
  • Significant cardiac arrhythmias
  • Significant valvular heart disease
  • Status asthmaticus
Show all 13Show fewer
  • Pulmonary hypertension
  • Pulmonary embolism
  • Pregnancy
  • Lower limb conditions preventing passive leg raising, including fractures
  • Intra-abdominal hypertension
  • Recent abdominal surgery
  • Known carotid artery disease or common carotid artery stenosis greater than 50%

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sana Zulfiqar, MBBS contact

+923335329538

sanazulfiqar53@gmail.com

Syed Muneeb Ali, MBBS, MCCM, MD CCM contact

+923335329538

Syed.muneeb.ali@gmail.com

Pakistan1 site, 1 recruiting
  • Pakistan Institute Of Medical Sciences

    Islamabad, Federal Area, 44000

    Syed Muneeb Ali, MBBS, MCCM, MD CCM, +923335329538, syed.muneeb.ali@gmail.com

    Recruiting

Other trials in Pakistan

About this study

Official title: Comparative Evaluation of Common Carotid Artery Blood Flow (CCABF) and Transthoracic Echocardiographic Cardiac Output (TTE-CO) for Assessing Fluid Responsiveness in Septic Patients on Ventilator.

The goal of this clinical trial is to determine whether common carotid artery blood flow measured by bedside Doppler ultrasound can accurately identify fluid responsiveness in mechanically ventilated adults with sepsis. The study will compare this method with transthoracic echocardiography-derived cardiac output, which is a commonly used non-invasive technique for assessing hemodynamic status in critically ill patients. The study also aims to evaluate whether carotid artery ultrasound can provide a faster and more practical bedside assessment during fluid resuscitation in the intensive care unit.

In patients with sepsis, giving too little intravenous fluid may worsen organ perfusion and shock, while excessive fluid administration may lead to complications such as pulmonary edema, worsening oxygenation, prolonged mechanical ventilation, and longer intensive care unit stay. Because of this, clinicians need reliable methods to identify which patients are likely to benefit from fluid administration. This concept is known as fluid responsiveness.

Read more

The main questions this study aims to answer are:

  • Can common carotid artery blood flow measured by ultrasound predict fluid responsiveness as accurately as transthoracic echocardiography-derived cardiac output?
  • How closely do changes in carotid artery blood flow correspond to changes in cardiac output during passive leg raising?
  • Can carotid ultrasound provide a quicker and simpler bedside method for assessing fluid responsiveness in critically ill patients receiving mechanical ventilation? Researchers will compare two ultrasound-based methods during a passive leg raising test. Passive leg raising is a temporary bedside maneuver used to simulate a fluid challenge without immediately giving intravenous fluids. During this maneuver, the patient's legs are elevated while the upper body is lowered, allowing blood from the lower limbs to temporarily return to the central circulation. This increases blood flow to the heart and may increase cardiac output in patients who are likely to respond to fluid administration.

The study team will first record baseline measurements of common carotid artery blood flow and transthoracic echocardiographic cardiac output while the patient is in a semi-recumbent position. The passive leg raising maneuver will then be performed, and both measurements will be repeated to evaluate changes in blood flow and cardiac output. If the predefined criteria for fluid responsiveness are met, the participant will receive intravenous crystalloid fluid according to the study protocol.

Participants will:

  • Undergo bedside Doppler ultrasound measurement of common carotid artery blood flow
  • Undergo transthoracic echocardiography to measure cardiac output
  • Have ultrasound measurements recorded before and after passive leg raising
  • Receive intravenous fluid administration if fluid responsiveness criteria are met
  • Continue routine monitoring of blood pressure, heart rate, oxygenation, urine output, and other intensive care parameters during the study period The findings from this study may help determine whether carotid artery ultrasound can be used as a practical bedside tool for fluid assessment in mechanically ventilated patients with sepsis, particularly in settings where rapid and non-invasive monitoring is needed.
Read the detailed description

This study is being conducted in the intensive care unit to examine a non-invasive ultrasound-based approach for evaluating circulatory response in adults with sepsis who are receiving mechanical ventilation. The investigation focuses on whether Doppler assessment of blood flow in the common carotid artery can provide clinically useful information comparable to cardiac output measurements obtained through transthoracic echocardiography during bedside hemodynamic assessment.

Management of septic patients frequently requires decisions regarding intravenous fluid administration. Both insufficient and excessive fluid therapy may negatively affect patient outcomes. Reliable bedside techniques that identify patients who are likely to benefit from additional fluid remain an important component of critical care practice. Current hemodynamic assessment methods often require specialized expertise, repeated examinations, or technically challenging image acquisition in ventilated patients.

This trial will assess circulatory changes produced by a passive leg raising maneuver. Passive leg raising temporarily increases venous return by transferring blood from the lower limbs toward the thoracic circulation. The maneuver provides a reversible physiologic preload challenge that allows evaluation of cardiovascular response without initially administering intravenous fluid.

Participants enrolled in the study will undergo sequential ultrasound-based hemodynamic assessments performed by trained investigators. Measurements will first be obtained while the participant is positioned with the head elevated. The participant will then undergo passive leg raising with elevation of both lower limbs and adjustment of trunk position according to study protocol. Repeat hemodynamic measurements will be recorded during the maneuver.

For carotid Doppler evaluation, the common carotid artery will be visualized in longitudinal orientation using a high-frequency linear ultrasound probe. Vessel diameter and Doppler flow measurements will be obtained from a standardized location proximal to the carotid bulb. Flow estimation will be derived from Doppler velocity measurements combined with arterial diameter and heart rate.

Cardiac output assessment will be performed separately using transthoracic echocardiography and Doppler evaluation of flow across the left ventricular outflow tract. Measurements will be obtained using standardized echocardiographic views and procedural methods.

Participants who demonstrate predefined hemodynamic changes during assessment may receive crystalloid administration according to the study protocol. Additional measurements may then be performed to evaluate circulatory response after fluid administration.

The primary analysis will evaluate the diagnostic performance of carotid Doppler-derived flow assessment for identifying preload responsiveness in comparison with transthoracic echocardiographic measurements. Agreement between both methods and the ability of carotid Doppler assessment to identify clinically significant hemodynamic change will also be examined.

Additional analyses will assess bedside practicality, including the ease and duration of ultrasound assessment in critically ill ventilated patients. Technical factors affecting image acquisition and measurement reliability will also be documented during the study.

Clinical information and ultrasound findings will be entered into standardized study forms. Data review procedures will include consistency checks, verification of recorded values, and evaluation of incomplete or missing variables before statistical analysis. Statistical methods will include correlation analysis, agreement testing, and calculation of diagnostic performance measures using predefined study thresholds.

This investigation may provide further evidence regarding the role of carotid Doppler ultrasound as a rapid bedside technique for circulatory assessment in mechanically ventilated adults with sepsis managed in the intensive care unit.

Being tested
intravenous crystalloid fluid bolus
Keywords
Fluid responsiveness, LVOT, Common carotid artery blood flow, Sepsis, TTE-CO, Carotid doppler, Ventilated patients
Medical subject headings
Sepsis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intravenous crystalloid fluid bolusDrug

    Intravenous isotonic crystalloid solution will be administered to participants who demonstrate predefined indicators of fluid responsiveness during hemodynamic assessment. A 500 mL fluid bolus will be infused according to intensive care unit protocol following passive leg raising-associated circulatory changes identified by ultrasound-based monitoring methods. Hemodynamic reassessment will be performed after fluid administration to evaluate changes in circulatory parameters.

Study groups in NCT07653568
Study groupRoleWhat they receive
Mechanically ventilated septic patients undergoing fluid responsiveness assessmentExperimentalParticipants enrolled in this study arm will undergo non-invasive bedside hemodynamic evaluation during passive leg raising. Doppler ultrasound of the common carotid artery and transthoracic echocardiographic assessment of cardiac output will be performed at predefined stages of assessment to examine circulatory changes associated with preload variation. Intravenous crystalloid administration may be provided when study-defined indicators of preload responsiveness are observed, followed by reassessment using the same ultrasound-based methods.
Receives: Drug: intravenous crystalloid fluid bolus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic Accuracy of Common Carotid Artery Blood Flow- Cardiac Output in predicting fluid responsiveness.

    This outcome will evaluate the ability of Doppler-derived common carotid artery blood flow measurements to identify fluid responsiveness in mechanically ventilated adults with sepsis using transthoracic echocardiography-derived cardiac output as the reference method. Diagnostic performance will be assessed through sensitivity, specificity, predictive values, overall accuracy, and agreement analysis during passive leg raising assessment.

    Measured: Peri-Procedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2026
  2. Study start1 May 2026
  3. Primary completion1 Jan 2027 (estimated)
  4. Study completion29 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
94 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07653568
Sponsor's protocol ID
20-4/AS&RB-M/SZAMU/2025-2378
Status last verified
Jun 2026
First submitted
4 Jun 2026
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Hylander Moller M, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337. No abstract available.

    PubMed 34605781

Questions about this trial

What is this clinical trial studying?

A study testing intravenous crystalloid fluid bolus in people with Fluid Responsiveness Predictability in Sepsis, run by Pakistan Institute of Medical Sciences at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sana Zulfiqar, MBBS (+923335329538, sanazulfiqar53@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic Accuracy of Common Carotid Artery Blood Flow- Cardiac Output in predicting fluid responsiveness. (time frame: Peri-Procedural). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07653568, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in